We are one of the few practices in the North Texas
area to prescribe

The U.S. Food and Drug Administration (FDA) has approved LATISSE™ (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.


LATISSE™ is the first and only science based treatment approved by the FDA to enhance eyelash prominence as measured by increased length, thickness and darkness of the eyelashes.


Dr Agustin Gonzalez, OD. FAAO

Dr Clarissa De Paz, OD

Dr Luis Robles, MD


Eye & Vision Privacy Policy
Eye & Vision Web Terms of use
Eye & Vision Trademarks

www.EyeandVision.net or www.RichardsonEyeDoctor.com